EP3782611

CELGENE
Application Number
EP20201105A
Filing Date
May 14, 2009
Status
Granted And Under Opposition
Jun 3, 2022
Grant Date
Jul 6, 2022
External Links
Slate, Register, Google Patents
Similar Patents facing opposition

Biblio Summary

The patent EP3782611B1 was granted to Celgene on Jul 6, 2022 following the initial filing on May 14, 2009 under the application number EP20201105A . The current legal status of the patent is Granted And Under Opposition.

AI Generated Summary New

Patent Family

Patent Oppositions filed by Competitors

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateOpposition Status

Get instant alerts for new oppositions and patent status changes

STADA ARZNEIMITTELApr 6, 2023ADMISSIBLE
TEVA PHARMACEUTICALSApr 4, 2023ADMISSIBLE
HAMM & WITTKOPPMar 31, 2023ADMISSIBLE
SANDOZMar 31, 2023ADMISSIBLE
SYNTHONMar 31, 2023ADMISSIBLE

Dossier Documents of the Patent

The dossier documents provide a comprehensive record of the patent’s prosecution history, including filings, correspondence, and decisions made by patent offices. These documents are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination. It also includes the oppositions documents filed against the patent.

  • Date

    Description

  • Get instant alerts for new documents